California ’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
Source: NYT Health - Category: Consumer Health News Authors: Benjamin Ryan Tags: Diabetes Drugs (Pharmaceuticals) Insulin Prices (Fares, Fees and Rates) Discount Selling Generic Brands and Products Inflation Reduction Act of 2022 Law and Legislation Government Contracts and Procurement biosimilars Eli Lilly and Com Source Type: news